Below are the Pharmacy Track sessions that were part of the 2022 Fall IDN Summit in Phoenix.
1:00 pm - 2:00 pm
Biosimilars: Clinical Adoption and Payer Considerations
Grand Saguaro West
The introduction of biosimilar products or products approved based on demonstrating that it is highly similar to an FDA-approved biologic product, has opened many possibilities in the field of pharmaceuticals. In this session, our panel of experts will explore the impact of biosimilars on patient care, how to get buy-in on biosimilars for clinicians, and opportunities for use of biosimilars in supply chain shortages.
1. Define biosimilars and their uses.
2. Outline how to get buy-in on biosimilars from clinicians.
3. Analyze the impact of biosimilars on patient care.
4. Demonstrate opportunities for biosimilars with supply chain shortages.
Payment is Everyone's Responsibility
Presenter: Bonnie Kirshenbaum, Consultant & Columnist
Site of care changes and payment rules enhancements are impacting your IDNs Pharmacy operations in 2022. In the third payment year amid the COVID-19 pandemic, navigating payment rules across sites of care and ensuring pharmacy is in sync with your organization’s overall strategies is critical. Themes observed in the rule sets include transparency rule clampdowns, patient centricity, continuing to simplify (electronic health record requirements and reporting, regulations), cut costs, and save money, and not lose focus on pharmacy’s efforts to combat the opioid crisis.
Additionally, we will cover late breaking changes including the Waste REFUND Act
In this session we will offer a complete understanding of the rule sets and discuss changes in strategy.